Shield Therapeutics Share Discussion Threads

[nobbygnome] 28/5/2019 21:40

I don't know if anyone else agrees with this but it feels like we all have a secret here which very few people know about. Yes the number of holders clearly went up recently at the £1 level but it is certainly very quiet on this BB. Meanwhile the price inexorably creeps higher almost on a daily basis.

I love it...what a hidden gem!

[ny boy] 28/5/2019 14:43

If you look back last week, a few more got mugged in the 100/110 area, every decade since the 20’s more have been mugged on each subsequent rise, it’s not for selling, just a binary bet with a good deal of risk reduced, not all, nothing is risk free in life, but a good percentage of risk is reduced, due to E.U. approval and subsequent sales throughout the EU and now into Switzerland.

Obviously the FDA approval would be the game changer, not forgetting a huge licensing deal in China, maybe by Q4 this year or HY 2020

Exciting times ahead...me thinks. Always dyor of course.

[montyhedge] 28/5/2019 14:41

Don't forget Norgine gave a 11 million pound upfront payment, so they are confident.

[montyhedge] 28/5/2019 14:33

255p on given the ok coming months, 85p on 28th July if not. Pay yer money take your chance. Market cap is peanuts, recent director buys, always encouraging.

[ny boy] 28/5/2019 10:03

Monty, they are already short listing licensing partners, once they know the FDA decision is favorable on 27 July they will choose the best partner going forward, so expect a big chunk of up front monies etc share price can easily double if FDA is “all systems go”

Investors are buying every small pull back each decade we go up and holding.

I am expecting at least 150p area just before 27 July dyor as usual.

[montyhedge] 28/5/2019 09:36

Market cap is peanuts, if they get the ok, wow companies lining up to do deals.

[ny boy] 28/5/2019 08:29

Morning all, onwards & upwards, once we break 115p, tick tock, new buyers coming in start of next month. Roll on 27 July!

[sharesoc] 27/5/2019 20:41

The Shield Therapeutics presentation from our London seminar on the 8th May are available for our full members to view here:

[montyhedge] 27/5/2019 10:56

I think it a good calculated speculation in favour 85% v 15%.

[nobbygnome] 26/5/2019 11:37

I think there are more than 2 possible outcomes. Clearly there is approval or not but also what the label says. Then hopefully shortly after the approval they will license the drug as the CEO said potential companies were lined up already and it was just a question of final bids once the label is known.

[montyhedge] 26/5/2019 11:18

All down to 27th July either 85p or 195p.

[sharestobuy] 24/5/2019 21:14

Its been mentioned £3 on or around 27th of July, not £2.55 this time next year

[ny boy] 24/5/2019 13:09

MM playing around, sometimes widening the spread, trying to knock out a few weak holders, low volume pre bank holiday trading.

Catch up next week as we move closer to 27 July, I expect new buying beginning of the new month

[montyhedge] 24/5/2019 10:34

Directors buys recently always I feel a good sign. I'm confident all being well 27th July, shareprice 255p this time next year.

[ny boy] 24/5/2019 08:39

As we have experienced since the 20’s, all mini pull backs/pull backs have been bought every decade by eager investors, keen to climb on board, looks like the same thing is repeating itself, 115p resistance remains until we start seeing closes above this level. Best just buy and hold and add more when there is a bit of a pull back always dyor

[montyhedge] 23/5/2019 20:33

Think your be lucky to get any around that price.

[ny boy] 23/5/2019 16:27

MM tree shake on low volume bank holiday weekend, have to admire them for effort lol!

Looking to add more if we see around 100p

[ny boy] 23/5/2019 08:32

Seems to be settling down around 115p resistance, volumes could be lighter as we wind down for bank holiday weekend.

Off myself later, have a good break all, catch up Tuesday

[montyhedge] 23/5/2019 08:31

No one knows the company like directors and recent buys are encouraging. Always like to see directors buy.

[montyhedge] 23/5/2019 07:17

Probably trade around 130p ish range before 27 July.Market cap is peanuts, if FDA approve I think shares will double, coming year. Only my thoughts.

[ny boy] 22/5/2019 19:39

This will go up to a level when investors start weighing up the risk/reward, I doubt much more than 150p pre FDA, 100k x 3 trades, just wondering if they were delayed buys or sells?

Anyway an exciting period ahead, if they pull the biggie off in the US, expect a great licensing deal from one of the several they are negotiating with, then the share price will power ahead! 🤞

[crankyman] 22/5/2019 16:38

I think the EMA saw IBD as a model for chronic ID. The FDA might/probably do need a third trial in another population to grant ID. What part the H2H can play in that, I’m not sure. Probably not much. They might need another trial - maybe in woman’s health.

[best1467] 22/5/2019 16:30

Don't base an FDA approval on the fact of EMA approval I know it sounds crazy but many drugs fail approval by FDAthat have been given EMA approval Fluitform springs to mind for one got EMA and Rest of world but not FDA I'm reasonably confident it's the Label they get is my main concern as I've said if we had the latest trial data I would be extremely confident

[crankyman] 22/5/2019 16:24

If you read the EMA docs they originally recommended an iron deficiency indication rather than IBD but the company argued for it to be restricted. Subsequently it was expanded. Now the FDA might restrict to IBD CKD or it might go to the whole ID population. I think that’s the uncertainty. Current sales and so price targets are based on that specialty care population. If the FDA grants ID and the US partner puts in the resources, the product could smash expectations.

[78steve] 22/5/2019 15:42

Well pretty much all medicines have side effects and as you say if not life threatening then why would you not allow it? People are already taking this in europe and i dont think there has been any fatalities from taking ferraccu